---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-019827"
form_type: "8-K"
ticker: "ZURA"
cik: "0001855644"
company_name: "Zura Bio Ltd"
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:47:50.310564+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Zura Bio prices $125M public offering of 18.2M shares at $6.25 and 1.8M pre-funded warrants

## Summary
- Offering: 18.2M Class A ordinary shares at $6.25/share, plus 1.8M pre-funded warrants at $6.249 each.
- Net proceeds expected ~$134.6M; underwriters' option for 3M additional shares exercised in full.
- Preliminary cash and equivalents as of Dec 31, 2025: ~$109.4M.
- Total outstanding ordinary shares after offering (excl. pre-funded warrants) ~94.9M.
- Offering expected to close Feb 26, 2026; joint bookrunners: Leerink, Piper Sandler, Cantor.

## SEC filing metadata
- accession: 0001104659-26-019827
- form_type: 8-K
- ticker: ZURA
- cik: 0001855644
- company_name: Zura Bio Ltd
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855644/000110465926019827/0001104659-26-019827-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855644/000110465926019827/tm267297d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-019827
- JSON: https://secwatch.observer/filing/0001104659-26-019827.json
- Plain text: https://secwatch.observer/filing/0001104659-26-019827.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.